Literature DB >> 10755497

Trends in medical use and abuse of opioid analgesics.

D E Joranson1, K M Ryan, A M Gilson, J L Dahl.   

Abstract

CONTEXT: Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs.
OBJECTIVE: To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. DESIGN AND
SETTING: Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data). PATIENTS: Nationally representative sample of hospital emergency department admissions resulting from drug abuse. MAIN OUTCOME MEASURES: Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population.
RESULTS: From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865).
CONCLUSIONS: The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.

Entities:  

Keywords:  Empirical Approach; Professional Patient Relationship

Mesh:

Substances:

Year:  2000        PMID: 10755497     DOI: 10.1001/jama.283.13.1710

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  97 in total

Review 1.  Implications of opioid analgesia for medically complicated patients.

Authors:  Howard Smith; Patricia Bruckenthal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

2.  Trends in consumption of opioid analgesics in Slovak Republic during 1998-2002.

Authors:  R Hudec; J Tisonová; L Bozeková; V Foltán
Journal:  Eur J Clin Pharmacol       Date:  2004-07-01       Impact factor: 2.953

3.  The association between prescribed opioid use for mothers and children: a record-linkage study.

Authors:  Tomas Log; Svetlana Skurtveit; Randi Selmer; Aage Tverdal; Kari Furu; Ingeborg Hartz
Journal:  Eur J Clin Pharmacol       Date:  2012-06-09       Impact factor: 2.953

4.  Substance misuse treatment for high-risk chronic pain patients on opioid therapy: a randomized trial.

Authors:  Robert N Jamison; Edgar L Ross; Edward Michna; Li Q Chen; Caroline Holcomb; Ajay D Wasan
Journal:  Pain       Date:  2010-03-23       Impact factor: 6.961

5.  Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain.

Authors:  Jane M Liebschutz; Richard Saitz; Roger D Weiss; Tali Averbuch; Sonia Schwartz; Ellen C Meltzer; Elizabeth Claggett-Borne; Howard Cabral; Jeffrey H Samet
Journal:  J Pain       Date:  2010-03-24       Impact factor: 5.820

6.  Medical and nonmedical use of prescription drugs among secondary school students.

Authors:  Sean Esteban McCabe; Carol J Boyd; Amy Young
Journal:  J Adolesc Health       Date:  2006-10-05       Impact factor: 5.012

7.  Adolescents' motivations to abuse prescription medications.

Authors:  Carol J Boyd; Sean Esteban McCabe; James A Cranford; Amy Young
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

Review 8.  Managing pain: The Challenge in Underserved Populations: Appropriate Use Versus Abuse and Diversion.

Authors:  Benny J Primm; Lucille Perez; Gary C Dennis; Lennette Benjamin; Westley Clark; Kathy Keough; W David Leak; Richard Payne; Deborah Smith; Louis W Sullivan
Journal:  J Natl Med Assoc       Date:  2004-09       Impact factor: 1.798

9.  Laboratory-induced cue reactivity among individuals with prescription opioid dependence.

Authors:  Sudie E Back; Daniel F Gros; Jenna L McCauley; Julianne C Flanagan; Elizabeth Cox; Kelly S Barth; Kathleen T Brady
Journal:  Addict Behav       Date:  2014-04-12       Impact factor: 3.913

10.  A prospective study of nonmedical use of prescription opioids during adolescence and subsequent substance use disorder symptoms in early midlife.

Authors:  Sean Esteban McCabe; Philip T Veliz; Carol J Boyd; Ty S Schepis; Vita V McCabe; John E Schulenberg
Journal:  Drug Alcohol Depend       Date:  2018-11-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.